中国现代医生
中國現代醫生
중국현대의생
CHINA MODERN DOCTOR
2015年
10期
100-102
,共3页
急性缺血性脑卒中%丹参多酚酸%神经功能
急性缺血性腦卒中%丹參多酚痠%神經功能
급성결혈성뇌졸중%단삼다분산%신경공능
Acute ischemic stroke%Salvianolate%Neurologic function
目的：研究丹参多酚酸对急性缺血性脑卒中的临床疗效。方法选取急性缺血性脑卒中患者200例，并随机分为观察组和对照组各100例。对照组采用内科常规治疗，观察组在常规治疗的基础上给予注射用丹参多酚酸治疗，两组均以14 d为1个疗程，观察患者的临床疗效、神经功能缺损情况、日常生活能力，比较两组治疗后效果。结果（1）观察组基本治愈14例，显著进步46例，进步31例，无效8例，加重1例，总有效率为91%，其总有效率显著高于对照组的75%（P<0.05）。（2）治疗后观察组的CNIHSS评分神经功能缺损情况和Barthel指数患者的日常生活能力改善程度显著优于对照组（P<0.05）。结论注射用丹参多酚酸对急性缺血性脑卒中有较好的疗效，可显著改善患者的神经功能缺损情况，提高患者的日常生活能力，且能显著改善急性缺血性脑卒中的微循环，增加脑部血液供应，保护脑细胞。
目的：研究丹參多酚痠對急性缺血性腦卒中的臨床療效。方法選取急性缺血性腦卒中患者200例，併隨機分為觀察組和對照組各100例。對照組採用內科常規治療，觀察組在常規治療的基礎上給予註射用丹參多酚痠治療，兩組均以14 d為1箇療程，觀察患者的臨床療效、神經功能缺損情況、日常生活能力，比較兩組治療後效果。結果（1）觀察組基本治愈14例，顯著進步46例，進步31例，無效8例，加重1例，總有效率為91%，其總有效率顯著高于對照組的75%（P<0.05）。（2）治療後觀察組的CNIHSS評分神經功能缺損情況和Barthel指數患者的日常生活能力改善程度顯著優于對照組（P<0.05）。結論註射用丹參多酚痠對急性缺血性腦卒中有較好的療效，可顯著改善患者的神經功能缺損情況，提高患者的日常生活能力，且能顯著改善急性缺血性腦卒中的微循環，增加腦部血液供應，保護腦細胞。
목적：연구단삼다분산대급성결혈성뇌졸중적림상료효。방법선취급성결혈성뇌졸중환자200례，병수궤분위관찰조화대조조각100례。대조조채용내과상규치료，관찰조재상규치료적기출상급여주사용단삼다분산치료，량조균이14 d위1개료정，관찰환자적림상료효、신경공능결손정황、일상생활능력，비교량조치료후효과。결과（1）관찰조기본치유14례，현저진보46례，진보31례，무효8례，가중1례，총유효솔위91%，기총유효솔현저고우대조조적75%（P<0.05）。（2）치료후관찰조적CNIHSS평분신경공능결손정황화Barthel지수환자적일상생활능력개선정도현저우우대조조（P<0.05）。결론주사용단삼다분산대급성결혈성뇌졸중유교호적료효，가현저개선환자적신경공능결손정황，제고환자적일상생활능력，차능현저개선급성결혈성뇌졸중적미순배，증가뇌부혈액공응，보호뇌세포。
Objective To study the clinical efficacy of salvianolate in acute ischemic stroke. Methods A total of 200 cases of acute ischemic stroke patients were chosen and randomly divided into the control group with 100 cases and the observation group with 100 cases. The control group received internal routine treatment, and the observation group received salvianolate treatment on the basis of routine treatment, both for 14 days as a course of treatment. Clinical ef-ficacies, neurological deficits and the daily life abilities of all the patients in the two groups after treatment were ob-served and compared. Results (1) 14 cases in the observation group were cured basically, 46 cases improved significantly, 31 cases improved, 8 cases were ineffective and one case aggravated. The total effective rate in the observation group was 91%, significantly higher than 75% in the control group (P<0.05). (2) Neurological deficits measured by CNIHSS score and the daily life abilities of patients measured by Barthel index in the observation group after treatment im-proved significantly better than those in the control group (P<0.05). Conclusion Salvianolate has a good effect in cur-ing acute ischemic stroke, and it can significantly improve the patients' neurological deficits and daily life abilities, salvianolate can significantly improve the microcirculation in acute ischemic stroke, increase blood supply to the brain and protect brain cells.
